 |
|
| CONTEMPORARY ASPECTS OF BIOMEDICAL RESEARCH, 57
| |
| | |
|
|
Drug Discovery
To order this title, and for more information, click here
S.J. Enna, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, USA
Michael Williams, Northwestern University, Chicago, IL, USA
Included in series
Advances in Pharmacology,
Contents
Drug Discovery - Michael Williams and S.J. Enna
Anti-inflammatory Agents as Cancer Therapeutics - Kho Kashfi
Proteasome
Inhibitors in Oncology - Bruce Ruggeri and Bruce Dorsey
TPA023: A Subtype-Selective GABAA
Receptor Modulator with a Novel Pharmacological Profile - John Atack
Problems with the Current Paradigm for Cancer Drug Development:
How to Win This Game - Bharat B. Aggarwal
New Approaches for the Treatment of Sleep Disorders - Andrew Winokur, Nick DeMartinis,
and Jayesh Kamath
Novel Strategies for Treating Hypercholesterolemia - Jerry Colca
Therapeutic
Strategies for the Treatment of Drug Addiction - Jonathan Katz and Amy Newman
Targets for Antihypertensives - David Taylor
and Abdel Abdel-Rahman
Metabotropic Glutamate Receptors as Targets for Antidepressants - Jeff Witkin
New Approaches
for the Treatment of Fibrosis - Alexander Scriabine.
Preclinical Prerequisites for Antipsychotic Activity - Vincent Castagne,
Paul C. Moser, and Roger Porsolt
| Bibliographic details |
Hardbound, 520 pages, publication date: DEC-2009
ISBN-13: 978-0-12-378642-5
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 135.99
USD 225
EUR 160.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/951
Last update: 10 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company